Displaying companies
Ouroboros Medicines is a biotechnology company that specializes in immunology and focuses on treating long-term immune-mediated illnesses. The company addresses chronic immune-mediated conditions directly by integrating scientific knowledge, a proven history of progressing cell-depleting treatments through clinical trials, and a strong pipeline. | San Francisco | CA | 20 - 50 | 2025 | $120,000,000 |
Helicore Biopharma is at the forefront of developing cutting-edge treatments for obesity and related disorders. | 5 - 10 | 2025 | $65,000,000 | ||
Tenvie Therapeutics is a biotechnology company founded to improve patients' lives with neurological, cardiometabolic, and ophthalmic diseases. The company is focused on developing small molecules targeting brain inflammation, metabolic dysfunction, and lysosomal issues, with a robust pipeline inherited from Denali Therapeutics. Tenvie is progressing a range of therapeutics aimed at addressing neurological, cardiometabolic, and ophthalmic conditions. Its collection of fully owned, highly brain-penetrant, and precisely designed peripherally restricted small molecules targets three main factors of disease: alleviating inflammation, correcting metabolic dysfunction, and rejuvenating lysosomal function. | San Francisco | CA | 20 - 50 | 2025 | $200,000,000 |
Newleos Therapeutics is a biotech startup dedicated to producing safer and more effective neuroscience medicines. | 10 - 50 | 2024 | $93,500,000 | ||
Praia Health is a cutting-edge consumer platform for health systems that transforms the delivery of personalised health solutions on a large scale, allowing digital transformation. | Chicago | IL | 20 - 50 | 2024 | $20,000,000 |
Converge Bio is at the forefront of integrating Generative AI with biological data. Our mission is to empower biotech and pharmaceutical companies to discover and develop more effective drugs faster, utilizing the power of Large Language Models (LLMs) specifically trained on biological languages. | Wilmington | DE | 20 - 50 | 2024 | $5,500,000 |
Advancing healthcare through adaptable and innovative inventory management solutions. | Haddonfield | NJ | 1 - 10 | 2024 | $1,250,000 |
Z-Score Health is a forward-thinking healthcare company leveraging technology to offer personalized preventive care. Their approach integrates comprehensive health risk assessments using a sophisticated SaaS platform and mobile applications, focusing on areas like women's health, geriatric care, and sexual health. They emphasize patient satisfaction and convenience, aiming to make healthcare more accessible and effective through technology. This summary provides an essence of their services and mission; for a detailed description, you would need to refer to their official website or professional profile. | Atlanta | GA | 1 - 10 | 2024 | $600,000 |
Cradle is a cryonics company that develops and proves the feasibility of human organs and whole-body reversible cryopreservation. That aims to focus on pausing and restarting biological functions through freezing to prevent tissue damage in dead bodies. | San Francisco | CA | 20 - 50 | 2024 | $48,000,000 |
Developing innovative therapeutics to materially improve the lives of patients. We strive to be transparent and open in our goals, plans, and progress. | San Diego | CA | 20 - 50 | 2024 | $370,000,000 |
GEMMABio is a therapeutics company that supports the rare disease community. | Philadelphia | PA | 50 - 100 | 2024 | $34,000,000 |
Bambusa Therapeutics operates as biotechnology company, that focuses on developing bispecific antibodies. | 10 - 50 | 2024 | $105,000,000 | ||
Mirador Therapeutics envisions precision medicine for immune-mediated inflammatory and fibrotic diseases. | San Diego | CA | 20 - 50 | 2024 | $480,000,000 |
Navigator Medicines operate as a biotech company that leads the advancement of biologics for targeted immune regulation & restoration. | Scotch Plains | NJ | 5 - 20 | 2024 | $100,000,000 |
Thrive AI Health builds an AI health coach. Thrive AI Health use generative AI to hyper-personalize and scale behavior change. | 10 - 50 | 2024 | $8,049,999 | ||
Jupiter Endovascular is a medical technology start-up. Its mission is to cover the entire spectrum of cardiovascular illness, seeing compelling potential to reinvent treatments for millions of people. | Menlo Park | CA | 10 - 50 | 2024 | $21,000,000 |
Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications. | Waltham | MA | 4 | 2024 | $602,600,000 |
Arini is an AI receptionist for dental practices that answers phone calls, and schedules appointments. | San Francisco | CA | 1 - 10 | 2024 | $500,000 |
Eyconis, Inc. is a privately held, pre-clinical stage biopharmaceutical company focused on transforming the ophthalmology treatment paradigm through the development, manufacture, and commercialization of novel, best-in-class therapeutics for eye diseases. The Company is advancing a pipeline of therapeutic candidates addressing areas of high unmet need including wet age-related macular degeneration (AMD). Eyconis is partnered with a syndicate of leading biopharma investors including Frazier Life Sciences, RA Capital Management, venBio Partners, and HealthQuest Capital. The Company is headquartered in Redwood City, California, including research & development laboratories with scientific and manufacturing team members. | 10 - 50 | 2024 | $85,251,248 | ||
Trovo Health uses AI technology to provide comprehensive healthcare solutions, combining smart algorithms with professional human coaching to deliver personalized patient care. | New York | NY | 10 - 50 | 2024 | $15,000,000 |
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence to learn the language of life and transform how we treat disease. The company seeks to rethink the drug discovery and development process from end-to-end by bringing together leading talent across three core areas: machine learning research to better understand biology, expansive data generation to power new models, and robust therapeutic product development to treat disease. Xaira is headquartered in the San Francisco Bay Area. | San Francisco | CA | 50 - 200 | 2024 | $1,000,000,000 |
Nura Health is a molecular diagnostics company whose mission is to advance women's health through the development and delivery of novel practice-changing non-invasive tests. We prioritize innovative, evidence-based diagnostic methods enhanced by AI & Machine Learning in order to improve clinical outcomes for complex and debilitating diseases such as endometriosis, infertility disorders, and genetic conditions that impact quality of life and longevity. | 1 - 10 | 2024 | |||
With a mission to keep athletes active and thriving in their chosen sports for as long as possible, Eternal provides members with a holistic understanding of their health, fitness, and benchmarks for key markers of the aging process along with guidance from high-performance care teams to support every stage of an athlete’s journey. | 10 - 50 | 2024 | $13,000,000 | ||
Endo Health creates a gamified ''AI endocrinologist'' for type 2 diabetes management. They are creating a pleasant AI medical assistant that will walk patients through every stage of diabetic control, complete with gamified involvement. | San Francisco | CA | 1 - 10 | 2024 | $1,000,000 |
careCycle is an AI workforce for Medicare agencies and FMOs, supporting top agencies in their operations. | 5 - 10 | 2024 | $2,000,000 | ||
Noded Ai is preparing yourself for that customer meeting is tough. Noded brings them all together using your notes history and gives you exactly what you needed , when you need it. So you’re always prepared and one step ahead. | New York | NY | 10 - 50 | 2024 | $48,000,000 |
Oma Care is to empower, assist, and compensate people who care for our most vulnerable citizens—family caregivers. | San Francisco | CA | 2 - 10 | 2024 | $500,000 |
Astrix builds AI purchasing agents for healthcare providers. Astrix helps providers secure better deals on recurring medical supplies, equipment, and pharmacy orders by using AI to find the best offers from reputable vendors. Powered by generative AI, Astrix aggregates and normalizes data from millions of sources, delivering actionable pricing insights for buyers and sellers alike. Our team brings expertise in building AI systems from Palantir, Oxford, Duke Health, and MedStar Health. Backed by Y Combinator, Astrix operates globally from San Francisco, NYC, and London. | 2 - 10 | 2024 | $2,000,000 | ||
Coeptis Therapeutics focuses on the development and acquisition of pharmaceutical products. Coeptis’ pipeline is evolving from the partnerships being created with multiple pharmaceutical companies currently. As these relationships unfold, the product pipeline will be updated accordingly. | Wexford | PA | 5 | 2024 | $25,192,500 |
Kivu Bioscience is a biotech company developing next-generation antibody-drug conjugates to deliver best-in-class therapeutics and focused on rapidly advancing next generation transformative assets. | San Francisco | CA | 5 - 20 | 2024 | $92,000,000 |
AT4K specializes in and alone performs in-person autism evaluations. It is committed to reducing the time it takes for children to be evaluated for Autism Spectrum Disorder (ASD) and providing comprehensive and reliable evaluations that enable early intervention and individualized care. | Grapevine | TX | 10 - 50 | 2024 | $2,500,000 |
Trace Neuroscience is a biopharmaceutical company that aims to extend the promise of genetic medicine to patients with neurodegenerative illnesses. | South San Francisco | CA | 10 - 50 | 2024 | $101,000,000 |
DeltaGen is an enterprise AI company transforming buyside M&A by automating 80% of manual workflows—eliminating inefficiencies and accelerating deal velocity for corporate development teams, private equity firms, and strategic acquirers. Unlike traditional AI tools that rely on manual prompting, DeltaGen’s no-prompt AI delivers highly accurate, deterministic insights with seamless integration. | 50 - 268 | 2024 | $2,700,000 | ||
Seaport Therapeutics operates as a clinical stage biopharmaceutical company. | Boston | MA | 20 - 100 | 2024 | $325,000,000 |
Zarminali Health is a medical organization. | Chicago | IL | 20 - 50 | 2024 | $40,000,000 |
Chai Discovery creates Chai-1, a multi-modal foundation model designed for predicting molecular structures relevant to drug discovery. The model facilitates the unified prediction of proteins, small molecules, and nucleic acids, and is available for free for commercial applications. By enabling accurate predictions without the need for multiple sequence alignments, Chai-1 advances the capabilities of molecular modeling in the life sciences. | San Francisco | CA | 5 - 20 | 2024 | $101,000,000 |
Alys Pharmaceuticals engages in immuno-dermatology services. The company is reshaping the treatment landscape through advanced scientific innovations and a strong research and development-focused multi-platform pipeline. Alys emerged as a result of the strategic aggregation of 6 asset-centric companies backed by Medicxi. | Boston | MA | 10 - 50 | 2024 | $100,000,000 |
Ambrosia Biosciences offers drug development services for small molecule-based therapies for obesity and other metabolic disorders. | Boulder | CO | 20 - 50 | 2024 | $41,000,000 |
GondolaBio is a clinical-stage biopharmaceutical company focused on developing next-generation therapeutics for genetic diseases. Originally launched as BridgeBioX, a subsidiary of BridgeBio, GondolaBio secured $300M in private financing from external investors in 2024 and became an independent company within the BridgeBio ecosystem. The company aims to leverage cutting-edge biological research to create breakthrough medicines addressing high unmet needs across multiple therapeutic areas, including neurology, pulmonology, cardiology, nephrology, and endocrinology. Located on the Stanford Life Sciences campus, GondolaBio fosters a unique hybrid environment where top scientists from around the world collaborate with senior leadership and advisors, blending industry expertise with academic innovation. | 20 - 100 | 2024 | $300,000,000 | ||
World Class Health is a Hospitals and Health Care company. | New York | NY | 1 - 10 | 2024 | |
Our HIPAA-Compliant AI Assistant will save you hours of paperwork time a week. Summarize parent interviews, caregiver trainings, and RBT supervision. Automate insight extraction from client records. Generate huge parts of treatment plans.
Interested in trying it out? No credit card required. No client data needed. Sign up for free! | 1 - 10 | 2024 | |||
KALM Therapeutics provides non-steroidical treatment for eczema and psoriasis. | Huntsville | AL | 2 - 10 | 2024 | $590,380 |
Kabilah streamlines shift change for nurses with an AI-powered assistant that replaces paper reports. | Stanford | CA | 1 - 10 | 2024 | $500,000 |
Kailera Therapeutics is a clinical-stage biotechnology company that provides revolutionary therapies for treating obesity and related diseases. | Waltham | MA | 50 - 200 | 2024 | $1,000,000,000 |
VisiRose offers an innovative approach to treating infectious keratitis and other eye diseases. | Knoxville | TN | 2 - 10 | 2024 | $3,000,000 |
nChroma Bio's integrated product engine allows for safe, accurate, and targeted in vivo administration, addressing major shortcomings of current genetic medicine techniques. | Boston | MA | 50 - 100 | 2024 | $75,000,000 |
Timberlyne Therapeutics is a clinical-stage biopharmaceutical company that develops and commercializes revolutionary medicines for autoimmune illnesses. The company utilizes its team's experience in drug development to secure top-tier assets focused on promising targets, and implementing them in disease areas with considerable unmet needs. | San Diego | CA | 10 - 50 | 2024 | $180,000,000 |
K-Scale Labs is a robotic engineering company specializing in creating open-source humanoid robots. | New York | NY | 2 - 10 | 2024 | $500,000 |
Lynch Regenerative Medicine is a healthcare company. | Franklin | TN | 10 - 50 | 2023 | $3,750,000 |
Synaptrix is committed to offering free of drugs, lasting alternatives for postoperative pain treatment using NOVABLOC. | Alpharetta | GA | 2 - 10 | 2023 | $10,000,000 |
Eris Biotech is a biotech company that developing hypoxia-activated prodrugs (HAPs) for the treatment of solid tumors. | American Fork | UT | 2 - 10 | 2023 | $500,000 |
Atraverse Medical offers a product development for left-heart access technology to simplify workflows and improve patient outcomes. | Chicago | IL | 20 - 50 | 2023 | $41,900,000 |
Althea is a healthcare and therapeutics company that offers psychedelic programs on health and consciousness. | Boulder | CO | 2 - 10 | 2023 | $1,500,000 |
Retension Pharmaceuticals is developing RTN-001, a differentiated, tissue-targeted PDE5 inhibitor that has been optimized for the treatment of uncontrolled hypertension. RTN-001 has been evaluated in over 265 subjects across 9 clinical trials. In these studies, RTN-001 was well tolerated and demonstrated a sustained and clinically significant impact on central and brachial blood pressure in patients with uncontrolled hypertension. RTN-001 is a second generation PDE5i that preferentially distributes to cardiovascular tissues, where it acts to mediate a sustained and clinically significant impact on central and brachial blood pressure in patients with uncontrolled hypertension. | Falls Church | VA | 2 - 10 | 2023 | $25,400,000 |
We are Montara Therapeutics, a San Francisco-based precision-medicine neuroscience biotech startup. Our team boasts significant experience from successful biotech firms such as Mitokinin, Denali, and Soteria, supported by a world-class Scientific Advisory Board (SAB).
We bring a new approach to tackling challenging established targets, along with unique experience in developing enzyme activators and domain expertise in mitophagy.
Our mission is to create innovative therapies for diseases of the CNS, with a focus on precision medicine and genetically validated targets to enhance drug safety and efficacy. | San Francisco | CA | 20 - 50 | 2023 | $31,300,000 |
Fortuna streamlines Medicaid navigation for consumers, covering eligibility, enrollment, and renewal processes seamlessly. | New York | NY | 5 - 20 | 2023 | $22,000,000 |
Aligned Marketplace operates as a personalized primary care for workforce. | New York | NY | 10 - 20 | 2023 | $11,000,000 |
ROSE Diagnostics' objective is to improve cancer diagnostics by moving the pathology lab to the cancer biopsy clinic and offering a suite of simple point-of-care diagnostic devices. | Carlsbad | CA | 1 - 10 | 2023 | $1,005,000 |
twenty30 health brings a technology-enabled, patient-first and coordinated, multimodal approach to delivery of obesity care. We deliver whole-person, evidence-based interventions, with a best-in-class provider network to drive sustained weight loss and metabolic health. | Philadelphia | PA | 10 - 50 | 2023 | $5,190,000 |
About HAPPY POTATO - Perfect Fries ! The world's best Flavored French Fries ! Feel the Flavor with everyone's favorite French fries Products Flavoring Perfect Fries | 10 - 100 | 2023 | $7,693,035 | ||
Enabling women's health providers to start, grow, and operate their own practices. | Dover | DE | 2 - 10 | 2023 | $500,000 |
Green Light Pet Hospital Melbourne provides emergency and specialized pet care services. | Ocoee | FL | 1 - 10 | 2023 | |
Mozarc Medical leverages both companies’ leadership and expertise to develop transformative kidney health technologies. The company focuses on the development of innovative technologies that reshape kidney health with patient-centered solutions. | Minneapolis | MN | 1,000 - 5,000 | 2023 | $22,399,376 |
Pranax is a software company currently based in Pinehurst, Texas, United States. It has been founded in 2023. | Pinehurst | TX | 2 - 10 | 2023 | $10,000,000 |
Citizen Health is the goal was to build a platform that allowed cancer patients seamless access to their data. When Nasha joined the company in 2018 and helped evolve its focus into rare disease, it became clear that this unique approach could unlock key clinical data and build a patient community that could fundamentally shift care for patients with rare diseases while accelerating cures. | 10 - 100 | 2023 | $44,622,088 | ||
Doron Therapeutics is a clinical-stage biotechnology company that has developed intra-articular biologic drugs derived from placental tissue and consistently delivers a host of beneficial growth factors with potent anti-inflammatory, tissue-protective, and regenerative capabilities pivotal to the progressive and degenerative disease of osteoarthritis. | Chapel Hill | NC | 5 - 10 | 2023 | $11,000,000 |
Advanced Medicine Partners is a biotechnology company that specializes in viral vector manufacturing for genes and cells. | Lake Forest | IL | 20 - 50 | 2023 | $32,000,000 |
SaaS for managing healthcare contracts and payments | New York | NY | 2 - 10 | 2023 | $3,000,000 |
Qualified Health is a reliable partner for safely utilizing generative AI in medicine. Qualified Health's infrastructure solution offers safeguards for ongoing algorithm performance monitoring, active AI governance, and developing agents tailored to the healthcare industry. Qualified Health are revolutionizing healthcare in America with top health system partners. | Miami Beach | FL | 20 - 50 | 2023 | $30,000,000 |
The Catch Mobile Health team brings together accomplished business and medical professionals from across the country with the shared vision to improve access to specialist care in rural and underserved communities. | 5 - 20 | 2023 | $2,275,000 | ||
Our mission is to help you reclaim your health from mold.
Learn more at www.moldco.com | Cambridge | MA | 1 - 10 | 2023 | |
Habitat Health was founded in 2023 to deliver fully integrated health and social care to older adults on Medicare or Medicaid who wish to remain living independently in their homes and communities. The company operates its model through the Program of All-Inclusive Care for the Elderly ("PACE") in collaboration with local community partners. The company is supported by Kaiser Permanente, Town Hall Ventures, and New Enterprise Associates. | 20 - 50 | 2023 | $50,000,000 | ||
For Henry is non-profit organization which raises funds for a child called Henry who is suffering from Alternating Hemiplegia of Childhood. | Washington, D.C. | 1 - 10 | 2023 | $2,500,000 | |
Taxa is a synthetic microbiome company sculpting the skin microbiome using genetic engineering technologies such as CRISPR/spCas9. | San Francisco | CA | 2 - 10 | 2023 | $2,500,000 |
Kenvue is a consumer health company that delivers personal health solutions. The company's brands have helped generations take care of themselves and their loved ones for more than 135 years. | Skillman | NJ | 22,000 | 2023 | $3,646,590,976 |
Conduce Health is an unprecedented healthcare technology company constructed to be a holistic solution for multi-specialty value-based care. | New York | NY | 10 - 50 | 2023 | $3,000,000 |
RapidClaims is redesigning the healthcare billing stack | New York | NY | 20 - 100 | 2023 | $11,100,000 |
Finding the right therapist can be difficult & intimidating. Foundation makes it easy to find a more personalized therapist match, so you can focus on your care and have confidence in your therapist understanding you. Foundation offers personalized therapist matches based on personality/communication style, easy scheduling, and access to diverse and available therapists. | New York | NY | 5 - 10 | 2023 | $825,000 |
Mindset assists mental illness caregivers in applying for Social Security Disability benefits for their loved one. | 10 - 200 | 2023 | $13,000,000 | ||
Mach5 Therapeutics is a biotechnology company. | Atlanta | GA | 1 - 10 | 2023 | $23,354,508 |
Tandem Health focuses on providing care, whereas Tandem allows you to conveniently make medical notes immediately following the patient session. Tandem Health creates technologies that simplify administration in healthcare. | 20 - 100 | 2023 | |||
Aureka Biotechnologies is a pioneering biotech firm dedicated to democratizing the pharmaceutical sector in order to conquer sickness. | Laguna Hills | CA | 10 - 50 | 2023 | $10,000,000 |
Junevity is a biotech rewinding complex metabolic disease. Based on 6 years of breakthrough research at UCSF, Junevity's REWIND platform identifies high-level regulators of metabolic disease with known pharmacological pathways. Junevity is advancing multiple therapeutic programs towards a new era of medicines. | 5 - 20 | 2023 | $10,000,000 | ||
We believe that everyone should have access to the healthcare they need, at a reasonable and transparent cost. We've built a platform which uses data to help employees save money on great healthcare options, from finding the right doctor, to saving money on prescription drugs, to fighting incorrect healthcare bills. | New York | NY | 10 - 50 | 2023 | $4,800,000 |
Juniver provides on-demand help, specialized care, and a supportive network for long-term recovery from eating disorders. | New York | NY | 5 - 10 | 2023 | $1,535,000 |
Silna handles all prior authorizations, benefit checks and insurance monitoring upfront to make sure your patients are clear to receive care, and you have more capacity to provide it. Silna Health focuses on helping specialty healthcare providers manage prior authorizations, benefits, and eligibility checks. Silna works with 1000+ payors across 45+ states supporting 50k+ patients. | 1 - 10 | 2023 | |||
Felix&Fido combines technology with operational excellence in a human-centered workplace to provide you with the best pet care possible. With multi-modal options, you never have to compromise on your pet's care. | Seattle | WA | 10 - 50 | 2023 | $4,000,000 |
Ti sento means “I hear you" in Italian. At Tisento Therapeutics, we believe that meaningful innovation requires understanding the problem, and that starts with listening. First and foremost, we listen to those impacted by debilitating diseases to understand the daily challenges they face. We also listen to healthcare providers, patient advocates, regulatory agencies, and scientific data. All these inputs inform our thinking and shape how we conduct our research, design our trials, and evolve our company. We are on a mission to deliver medicines that address what matters most. Our lead candidate is zagociguat (formerly CY6463), a Phase 2, first-in-class, brain-penetrant sGC stimulator, which is advancing in MELAS and other genetic mitochondrial diseases. Zagociguat is ideally suited to treat mitochondrial diseases with both CNS and peripheral symptoms, such as cognitive impairment, fatigue, and muscle weakness. | 10 - 50 | 2023 | $91,000,000 | ||
Spyre Therapeutics combines best-in-class antibody engineering, rational therapeutic combinations, and precision immunology approaches to maximize efficacy, safety, and convenience of treatments for inflammatory bowel disease. | San Francisco | CA | 87 | 2023 | $1,100,999,936 |
Optain is a manufacturer of medical equipment and software. Optain is to make healthcare available to all people so that all can live healthy lives. Optain uses AI to create affordable clinical assistance solutions that make illness screening simple, anytime, and anywhere. | New York | NY | 10 - 50 | 2023 | $38,000,000 |
Attovia Therapeutics is a biotherapeutics pipeline developer focused on immune-mediated illness and oncology. The company uses the nanobody platform to create tiny format binders with low picomolar affinity, increased selectivity, quicker internalization, and rapid tissue penetration, thereby assisting cancer patients' treatment. | Fremont | CA | 20 - 50 | 2023 | $255,000,000 |
Somite is a mission to transform the lives of millions of people by leveraging AI to produce human tissue for cell-based therapies. | Salt Lake City | UT | 10 - 50 | 2023 | $57,295,000 |
In-House Health is an AI-powered technical platform for modern nursing teams. | Denver | CO | 10 - 50 | 2023 | $4,000,000 |
Predicta Biosciences is a precision oncology firm that integrates multiomics and liquid biopsies to create diagnostic tools and therapies. They also have an in-house pipeline for novel immunotherapy targets in pre-clinical stages. | Boston | MA | 5 - 10 | 2023 | $28,600,000 |
Decoda Health (YC S23) transforms healthcare administration with AI-driven medical assistants, empowering staff to shift their focus from tedious tasks to what truly matters — providing exceptional patient care. | San Francisco | CA | 2 - 10 | 2023 | $500,000 |
AHEAD Medicine utilizes artificial intelligence and machine learning to transform cell-level data into insights | Berkeley | CA | 5 - 20 | 2023 | $1,600,000 |
Personalized weight loss backed by science. Eden's elite team of board-certified doctors and pharmacists specializes in weight loss and metabolic health, offering proven prescriptions and continuous support for tangible outcomes. | 10 - 20 | 2023 | |||
SynsoryBio is a biotechnology research company that offers next-generation protein therapeutics services. | Somerville | MA | 1 - 10 | 2023 | $500,000 |
Caladan Bio specializes in next-generation bioreactors, offering modular, affordable, and cutting-edge solutions. | New York | NY | 2 - 10 | 2023 | $5,100,000 |
Tern Therapeutics develops transformative, one-time genetic treatments for rare diseases. | 2 - 10 | 2023 | $15,000,000 |
From job listings to startups, investors to funding rounds, and everything in between, Employbl puts the power in your hands. Why wait?
Start your free trial today!Sign up for our newsletter to stay informed about the latest startups and trends in the tech market. Let Employbl be your guide to success.